In the last trading session, 1.45 million Viridian Therapeutics Inc (NASDAQ:VRDN) shares changed hands as the company’s beta touched 0.43. With the company’s per share price at $13.82 changed hands at $1.0 or 7.80% during last session, the market valuation stood at $1.13B. VRDN’s last price was a discount, traded about -96.82% off its 52-week high of $27.20. The share price had its 52-week low at $9.90, which suggests the last value was 28.36% up since then.
Analysts gave the Viridian Therapeutics Inc (VRDN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.24. If we narrow down to specifics, the data shows that 0 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended VRDN as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight.
Viridian Therapeutics Inc (NASDAQ:VRDN) trade information
Instantly VRDN was in green as seen at the end of in last trading. With action 7.88%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -27.91%, with the 5-day performance at 7.88% in the green. However, in the 30-day time frame, Viridian Therapeutics Inc (NASDAQ:VRDN) is 5.26% up.
The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 37.18% from its current market value. According to analyst projections, VRDN’s forecast low is 13.5 with 45 as the target high. To hit the forecast high, the stock’s price needs a -225.62% plunge from its current level, while the stock would need to tank 2.32% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 31.28%. The 2025 estimates are for Viridian Therapeutics Inc earnings to decrease by -8.15%, but the outlook for the next 5-year period is at 18.32% per year.
VRDN Dividends
Viridian Therapeutics Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.4758% or 4.77 million shares worth $62.1 million as of 2024-06-30.
